Trial Library
Trial Library is an AI-native platform integrating clinical trials into routine care across health systems, biopharma, and payers.
Founded
2022Trial Library is an AI-native platform integrating clinical trials into routine care across health systems, biopharma, and payers.
Trial Library advantages start with representative-enrollment data and a community network of more than 3000 providers across over 840 clinic sites, giving sponsors reach beyond academic centers. Referral workflows complete in under a minute, compressing the provider effort that typically stalls community enrollment.
Its Navigation OS addresses transport, food, language, and scheduling barriers that cause enrolled patients to drop out before completion. The company cites 642 referrals at The Oncology Institute within one year as evidence that barrier navigation converts identification into completed enrollment.
Source: triallibrary.com
Trial Library operates at the intersection of community oncology networks, academic research centers, biopharma sponsors, and payer-backed trial benefits. Named collaborators and customers span The Oncology Institute, Texas Oncology, and the American Oncology Network alongside Johnson and Johnson Innovative Medicine and the American Cancer Society.
The outlook rests on sponsors shifting enrollment work into community settings where most patients receive care, and on payers treating trial access as a covered benefit. Continued expansion of the provider and clinic network is the leading indicator for whether that community-led enrollment thesis holds.
Source: triallibrary.com
Trial Library is an AI-native clinical-trial access platform built around four modules: provider activation with pre-screening and referral workflows, referral optimization through site augmentation, a Navigation OS that supports patients through completion, and conversational trial search for medical-affairs teams. Together these modules move a patient from eligibility identification to enrolled and supported participation.
The platform sells into three buyer lanes: sponsors seeking enrolled patients across a community network, providers and health systems seeking sub-minute referral workflows, and payers and employers seeking trial-access benefits. Its positioning centers on embedding trials in routine care rather than operating a standalone patient-matching site.
Source: triallibrary.com